Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-06
DOI
10.1186/s12967-020-02652-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
- (2020) Sandra Muñoz-Galván et al. Molecular Cancer
- LncRNA BLACAT1 Is Upregulated in Cervical Squamous Cell Carcinoma (CSCC) and Predicts Poor Survival
- (2020) Hailing Cheng et al. Reproductive Sciences
- microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways
- (2020) Sajjad Masoumi-Dehghi et al. Journal of Cell Communication and Signaling
- MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway
- (2019) Jinghui Hu et al. Cancer Cell International
- Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23
- (2019) Tong Li et al. CELL CYCLE
- The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches
- (2019) Changwon Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Modulation of Myb‐induced NF‐kB ‐STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors
- (2019) Miao Tian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study
- (2019) C. Khalil et al. Journal of Ovarian Research
- Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer
- (2019) E. Richardsen et al. Scientific Reports
- The potential roles of stem cell-derived extracellular vesicles as a therapeutic tool
- (2019) Yu-Chin Huang et al. Annals of Translational Medicine
- The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
- (2018) Andrea Mohr et al. CANCER LETTERS
- Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer
- (2018) Jingjing Liu et al. CELL CYCLE
- Shedding light on the cell biology of extracellular vesicles
- (2018) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MiR-150 suppresses tumor growth in melanoma through downregulation of MYB
- (2018) Xiyan Sun et al. ONCOLOGY RESEARCH
- Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer
- (2018) Fu Hua et al. ONCOLOGY RESEARCH
- Exosomal microRNAs as tumor markers in epithelial ovarian cancer
- (2018) Chi Pan et al. Molecular Oncology
- The activation of microRNA-520h–associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression
- (2018) Jing Zhang et al. Cell Death & Disease
- Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
- (2018) Jieru Zhou et al. Cancer Immunology Research
- Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
- (2018) Pinar Kanlikilicer et al. EBioMedicine
- Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients
- (2017) Gregory M. Heestand et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-424 inhibits cell migration, invasion, and epithelial mesenchymal transition by downregulating doublecortin-like kinase 1 in ovarian clear cell carcinoma
- (2017) Xin Wu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α
- (2016) Fumihiko Okumura et al. MOLECULAR AND CELLULAR BIOLOGY
- miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer
- (2016) Xia Wang et al. Oncotarget
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells
- (2016) Shixia Bu et al. Scientific Reports
- Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells
- (2016) Abu Musa Md Talimur Reza et al. Scientific Reports
- TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin
- (2015) J. Erriquez et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb
- (2014) Lei Yu et al. PLoS One
- Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors
- (2012) Cecilia Lässer EXPERT OPINION ON BIOLOGICAL THERAPY
- Down-Regulation of mir-424 Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile Hemangioma: Its Implications to Therapy
- (2010) Taiji Nakashima et al. PLoS One
- miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
- (2009) R I Aqeilan et al. CELL DEATH AND DIFFERENTIATION
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started